You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Cerevance, a drug discovery firm employing the transcriptome sequencing method, raised $45 million in Series B financing earlier this month.
The firm recently published a paper with its sibling company HiFiBio on antibody sequencing, but is looking to develop more applications.
A new analysis finds that peer review improves the quality of preprints just a little bit, according to ScienceInsider.
The firm's single-cell T cell receptor profiling method was published this month as part of a study to develop reusable antigen reactivity screens.
The method uses nanopore sequencing to analyze short cell-free DNA fragments from blood, providing results in as little as six hours.
All three methods build on the use of methyltransferases to mark accessible regions of the genome, using nanopore sequencing to detect the modifications.
The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.
The study, led by NYU researchers, provides a mathematical framework to find gene sets identifiable via both methods, revealing tissue architecture.
The New York Times reports academic researchers often work right through the holidays and over the weekends.
A new analysis in The BMJ finds that male authors are more likely to use terms like "novel," "unique," or "unprecedented" when describing their work, which leads to more citations.
A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.
US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.
According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.
In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.